Design and synthesis of N-alkylated saccharins as selective alpha-1A adrenergic receptor antagonists

Cited 11 time in webofscience Cited 12 time in scopus
  • Hit : 464
  • Download : 0
DC FieldValueLanguage
dc.contributor.authorNerenberg, JBko
dc.contributor.authorErb, JMko
dc.contributor.authorThompson, WJko
dc.contributor.authorLee, Hee Yoonko
dc.contributor.authorGuare, JPko
dc.contributor.authorMunson, PMko
dc.contributor.authorBergman, JMko
dc.contributor.authorHuff, JRko
dc.contributor.authorBroten, TPko
dc.contributor.authorChang, RSLko
dc.contributor.authorChen, TBko
dc.contributor.authorO'Malley, Sko
dc.contributor.authorSchorn, TWko
dc.contributor.authorScott, ALko
dc.date.accessioned2013-02-27T23:46:18Z-
dc.date.available2013-02-27T23:46:18Z-
dc.date.created2012-02-06-
dc.date.created2012-02-06-
dc.date.issued1998-09-
dc.identifier.citationBIOORGANIC MEDICINAL CHEMISTRY LETTERS, v.8, no.18, pp.2467 - 2472-
dc.identifier.issn0960-894X-
dc.identifier.urihttp://hdl.handle.net/10203/71556-
dc.description.abstractBenign prostatic hyperplasia can be managed pharmacologically with alpha-1 adrenergic receptor antagonists. Agents that demonstrate selectivity for the alpha-1a receptor subtype may offer advantages in clinical applications with respect to hypotensive side effects. The N-alkylated saccharins reported here represent a new class of subtype selective alpha-1a adrenergic receptor antagonists which demonstrate potent effects on prostate function in vivo and are devoid of blood pressure side effects. (C) 1998 Elsevier Science Ltd. All rights reserved.-
dc.languageEnglish-
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD-
dc.subjectBENIGN PROSTATIC HYPERPLASIA-
dc.subjectALPHA(1C)-
dc.subjectEFFICACY-
dc.subjectSAFETY-
dc.titleDesign and synthesis of N-alkylated saccharins as selective alpha-1A adrenergic receptor antagonists-
dc.typeArticle-
dc.identifier.wosid000076271200012-
dc.identifier.scopusid2-s2.0-16744364284-
dc.type.rimsART-
dc.citation.volume8-
dc.citation.issue18-
dc.citation.beginningpage2467-
dc.citation.endingpage2472-
dc.citation.publicationnameBIOORGANIC MEDICINAL CHEMISTRY LETTERS-
dc.identifier.doi10.1016/S0960-894X(98)00446-6-
dc.contributor.localauthorLee, Hee Yoon-
dc.contributor.nonIdAuthorNerenberg, JB-
dc.contributor.nonIdAuthorErb, JM-
dc.contributor.nonIdAuthorThompson, WJ-
dc.contributor.nonIdAuthorGuare, JP-
dc.contributor.nonIdAuthorMunson, PM-
dc.contributor.nonIdAuthorBergman, JM-
dc.contributor.nonIdAuthorHuff, JR-
dc.contributor.nonIdAuthorBroten, TP-
dc.contributor.nonIdAuthorChang, RSL-
dc.contributor.nonIdAuthorChen, TB-
dc.contributor.nonIdAuthorO'Malley, S-
dc.contributor.nonIdAuthorSchorn, TW-
dc.contributor.nonIdAuthorScott, AL-
dc.type.journalArticleArticle; Proceedings Paper-
dc.subject.keywordPlusBENIGN PROSTATIC HYPERPLASIA-
dc.subject.keywordPlusALPHA(1C)-
dc.subject.keywordPlusEFFICACY-
dc.subject.keywordPlusSAFETY-
Appears in Collection
CH-Journal Papers(저널논문)
Files in This Item
There are no files associated with this item.
This item is cited by other documents in WoS
⊙ Detail Information in WoSⓡ Click to see webofscience_button
⊙ Cited 11 items in WoS Click to see citing articles in records_button

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0